Core Insights - Orchestra BioMed Holdings (NASDAQ: OBIO) is experiencing significant momentum that is not yet reflected in its stock price [1] - The company possesses two proprietary medical device therapies that target large, established markets [1] Company Overview - Orchestra BioMed Holdings focuses on innovative medical device therapies [1] - The company is positioned in the biotech and pharmaceutical sectors, which are known for their growth potential [1] Market Potential - The medical device therapies owned by the company are considered best-in-class, indicating a strong competitive advantage [1] - The target markets for these therapies are large and well-established, suggesting substantial revenue opportunities [1]